Literature DB >> 27488820

Pleural fluid adenosine deaminase/serum C-reactive protein ratio for the differentiation of tuberculous and parapneumonic effusions with neutrophilic predominance and high adenosine deaminase levels.

Jaehee Lee1, Seung Soo Yoo1, Shin Yup Lee1, Seung Ick Cha1, Jae Yong Park1, Chang Ho Kim2.   

Abstract

PURPOSE: Tuberculous pleural effusion (TPE) and parapneumonic effusion (PPE) are usually distinguished by cellular predominance and pleural fluid adenosine deaminase (ADA) levels. However, both diseases may occasionally show similar neutrophilic predominance and high ADA levels. In such cases, the differential diagnosis between TPE and PPE is challenging and has been rarely investigated.
METHODS: A retrospective study was conducted on TPE and PPE patients with neutrophilic exudate and pleural fluid ADA levels ≥40 U/L. Individual and combined parameters of routine blood and pleural fluid tests were compared between the two groups, and receiver operating characteristic (ROC) curves were constructed for identifying TPE.
RESULTS: Thirty-six TPE and 41 PPE patients were included. White blood cell counts, serum C-reactive protein (S-CRP), and pleural fluid pH, lactate dehydrogenase, and ADA levels showed significant difference between the two groups (p < 0.001). Among multiple parameters, pleural fluid ADA/S-CRP ratio, which best reflected different local and systemic characteristics between TPE and PPE, provided the highest diagnostic accuracy with an area under the ROC curve of 0.93. At a cutoff value of 5.62, ADA/S-CRP ratio had a sensitivity of 89 %, specificity of 88 %, positive likelihood ratio of 7.29, and negative likelihood ratio of 0.13 for identifying TPE. Additionally, more than half of TPE patients had a ratio above 15.82, while none of PPE patients showed such findings.
CONCLUSIONS: Pleural fluid ADA/S-CRP ratio, as a simple method using routine laboratory tests, may be helpful in discriminating between TPE and PPE patients with neutrophilic predominance and ADA ≥40 U/L.

Entities:  

Keywords:  Adenosine deaminase; C-reactive protein; Neutrophilic predominance; Parapneumonic effusion; Tuberculous pleural effusion

Mesh:

Substances:

Year:  2016        PMID: 27488820     DOI: 10.1007/s15010-016-0928-5

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  22 in total

1.  Usefulness of the British Thoracic Society and the American College of Chest Physicians guidelines in predicting pleural drainage of non-purulent parapneumonic effusions.

Authors:  José Manuel Porcel; Manuel Vives; Aureli Esquerda; Agustín Ruiz
Journal:  Respir Med       Date:  2005-10-25       Impact factor: 3.415

2.  Serum C-reactive protein levels in disease.

Authors:  J J Morley; I Kushner
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

Review 3.  Pleural fluid tests to identify complicated parapneumonic effusions.

Authors:  José M Porcel
Journal:  Curr Opin Pulm Med       Date:  2010-07       Impact factor: 3.155

Review 4.  Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline.

Authors:  G L Colice; A Curtis; J Deslauriers; J Heffner; R Light; B Littenberg; S Sahn; R A Weinstein; R D Yusen
Journal:  Chest       Date:  2000-10       Impact factor: 9.410

5.  Accuracy of polimerase chain reaction for the diagnosis of pleural tuberculosis.

Authors:  Anete Trajman; Elen Fabricia da Silva Santos Kleiz de Oliveira; Mayara Lisboa Bastos; Epaminondas Belo Neto; Edgar Manoel Silva; Maria Cristina da Silva Lourenço; Afrânio Kritski; Martha Maria Oliveira
Journal:  Respir Med       Date:  2014-04-23       Impact factor: 3.415

6.  Role of common investigations in aetiological evaluation of exudative pleural effusions.

Authors:  Arnab Maji; Malay Kumar Maikap; Debraj Jash; Kaushik Saha; Abhijit Kundu; Debabrata Saha; Sourindranath Banerjee; Anupam Patra
Journal:  J Clin Diagn Res       Date:  2013-09-16

Review 7.  Tuberculous pleural effusion.

Authors:  José M Porcel
Journal:  Lung       Date:  2009-08-13       Impact factor: 2.584

Review 8.  Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis.

Authors:  Qiu-Li Liang; Huan-Zhong Shi; Ke Wang; Shou-Ming Qin; Xue-Jun Qin
Journal:  Respir Med       Date:  2008-01-28       Impact factor: 3.415

9.  Biomarkers of infection for the differential diagnosis of pleural effusions.

Authors:  J M Porcel; M Vives; G Cao; S Bielsa; A Ruiz-González; A Martínez-Iribarren; A Esquerda
Journal:  Eur Respir J       Date:  2009-06-18       Impact factor: 16.671

Review 10.  Tuberculous pleurisy: an update.

Authors:  Doosoo Jeon
Journal:  Tuberc Respir Dis (Seoul)       Date:  2014-04-25
View more
  10 in total

1.  Diagnostic performance of C-reactive protein for parapneumonic pleural effusion: a meta-analysis.

Authors:  Dajiang Li; Yongchun Shen; Jiangyue Qin; Chun Wan; Ni Zeng; Lei Chen; Yue Dong
Journal:  Ann Transl Med       Date:  2019-01

2.  Differential diagnosis between lymphoma-associated malignant pleural effusion and tuberculous pleural effusion.

Authors:  Chang Ho Kim; Hong Geun Oh; Sang Yub Lee; Jae Kwang Lim; Yong Hoon Lee; Hyewon Seo; Seung Soo Yoo; Shin Yup Lee; Seung Ick Cha; Jae Yong Park; Jaehee Lee
Journal:  Ann Transl Med       Date:  2019-08

3.  Clinical significance of Glasgow Prognostic Score in patients with tuberculous pleurisy.

Authors:  Hye Seon Kang; Hwa Young Lee; Jung Im Jung; Ju Sang Kim; Yong Hyun Kim; Seung Joon Kim; Seok Chan Kim; Soon Seog Kwon; Young Kyoon Kim; Ji Young Kang
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

4.  The pleural fluid lactate dehydrogenase/adenosine deaminase ratio differentiates between tuberculous and parapneumonic pleural effusions.

Authors:  Jinlin Wang; Jun Liu; Xiaohong Xie; Panxiao Shen; Jianxing He; Yunxiang Zeng
Journal:  BMC Pulm Med       Date:  2017-12-04       Impact factor: 3.317

5.  Diagnostic value of polymerase chain reaction/acid-fast bacilli in conjunction with computed tomography-guided pleural biopsy in tuberculous pleurisy: A diagnostic accuracy study.

Authors:  Lei Li; Ye Wang; Rui Zhang; Dan Liu; Yalun Li; Yongzhao Zhou; Juan Song; Weimin Li; Panwen Tian
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

6.  A retrospective study on the combined biomarkers and ratios in serum and pleural fluid to distinguish the multiple types of pleural effusion.

Authors:  Liyan Lin; Shuguang Li; Qiao Xiong; Hui Wang
Journal:  BMC Pulm Med       Date:  2021-03-19       Impact factor: 3.317

Review 7.  Mycoplasma pneumoniae Pleural Effusion in Adults.

Authors:  Chang Ho Kim; Jaehee Lee
Journal:  J Clin Med       Date:  2022-02-26       Impact factor: 4.241

8.  Development and validation of a novel scoring system developed from a nomogram to identify malignant pleural effusion.

Authors:  Sufei Wang; Shan Tian; Yuan Li; Na Zhan; Yingyun Guo; Yu Liu; Juanjuan Xu; Yanling Ma; Shujing Zhang; Siwei Song; Wei Geng; Hui Xia; Pei Ma; Xuan Wang; Tingting Liao; Yanran Duan; Yang Jin; Weiguo Dong
Journal:  EBioMedicine       Date:  2020-07-30       Impact factor: 8.143

9.  Laboratory and radiological discrimination between tuberculous and malignant pleural effusions with high adenosine deaminase levels.

Authors:  Jaehee Lee; Ji Eun Park; Sun Ha Choi; Hyewon Seo; Sang Yub Lee; Jae Kwang Lim; Seung Soo Yoo; Shin Yup Lee; Seung Ick Cha; Jae Yong Park; Chang Ho Kim
Journal:  Korean J Intern Med       Date:  2021-07-15       Impact factor: 2.884

10.  Pleural Fluid GSDMD Is a Novel Biomarker for the Early Differential Diagnosis of Pleural Effusion.

Authors:  Pu Li; Jing Shi; Lijing Zhou; Bo Wang; Li Jun Zhang; Liang Duan; Qin Hu; Xiaolan Zhou; Yuan Yuan; Dandan Li; Hong Chen; Qing Zhao; Xuemei Peng; Weixian Chen
Journal:  Front Microbiol       Date:  2021-06-07       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.